Press release

Truveta announces availability of millions of echocardiogram reports to advance cardiovascular research

BELLEVUE, Wash., Nov. 08, 2023 (GLOBE NEWSWIRE) -- Today Truveta announced the availability of more than 56.6 million clinical observations from more than 2.7 million echocardiogram reports from more than 1.7 million de-identified patients, making it the market leader in real-world data to advance cardiovascular research at scale. Truveta delivers the most complete, timely, and clean electronic health record (EHR) data from more than 100 million patients across more than 30 health systems, empowering researchers with scientifically rigorous analytics to study safety and effectiveness, improve patient care, and train medical AI. New peer-reviewed research using Truveta Data was published recently in the Journal of the Society for Cardiovascular Angiography and Interventions (JSCAI) comparing two treatments for pulmonary embolism and identifying risk for adverse events like major bleeding. Major life sciences organizations like Boston Scientific and Reprieve Cardiovascular are also using Truveta to explore conditions like peripheral artery disease (PAD) and acute decompensated heart failure (ADHF) to advance therapeutic innovations and improve patient care and outcomes.

Echocardiograms provide crucial clinical observations for cardiovascular care, yet obtaining these measures at scale for real-world data analysis has been a longstanding challenge. Existing methods, such as relying on registry data or physician referrals, have limitations in ...

Full story available on

Disclaimer: The views, recommendations, and opinions expressed in this content belong solely to the third-party experts. This site was not involved in the writing and production of this article.

Disclaimer Press Release Banner

More to read